CVS

CVS HEALTH
D

CVS

Arincen56/100B

CVS HEALTH balance sheet 1985–2026

CVS HEALTH had 14.89B USD in cash and short-term investments on 30 September 2026, against total debt of 75.30B USD: net debt of 60.41B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
11.74B8.51B8.59B8.20B12.95B9.41B7.85B5.68B4.06B1.70B3.37B
Short-term investments
3.15B2.15B2.41B3.26B2.78B3.12B3.00B2.37B2.52B111.00M87.00M
14.89B10.66B10.99B11.46B15.72B12.53B10.85B8.06B6.58B1.81B3.46B
Cash growth
+31.87%-3.06%-4.03%-27.14%+25.53%+15.40%+34.73%+22.41%+264.19%-47.74%+35.77%
Receivables
42.07B39.78B36.47B35.23B27.28B24.43B21.74B19.62B17.63B13.18B12.16B
Inventory
18.24B19.25B18.11B18.03B19.09B17.76B18.50B17.52B16.45B15.30B14.76B
Other current assets
4.19B5.03B3.08B3.15B3.54B5.29B5.28B5.11B4.58B945.00M660.00M
Total current assets
79.39B74.71B68.65B67.86B65.63B60.01B56.37B50.30B45.24B31.23B31.04B
Property, plant and equipment
27.55B28.06B28.94B30.44B30.75B32.02B33.34B32.90B11.35B10.29B10.18B
Long-term investments
34.07B32.87B28.93B23.02B21.10B23.03B20.81B17.31B15.73B112.00M0.00
Goodwill and intangibles
109.70B110.99B118.60B120.51B102.95B108.15B110.69B112.87B115.20B52.08B51.76B
Goodwill
85.48B85.48B91.27B91.27B78.15B79.12B79.55B79.75B78.68B38.45B38.25B
Intangible assets
24.22B25.51B27.32B29.23B24.80B29.03B31.14B33.12B36.52B13.63B13.51B
Other non-current assets
7.37B6.91B8.10B7.91B7.85B9.80B9.51B9.06B8.93B1.42B1.49B
Total assets
258.08B261.06B253.22B249.73B228.28B233.00B230.72B222.45B196.46B95.13B94.46B
Accounts payable
17.88B59.38B15.89B14.90B14.84B12.54B11.14B10.49B8.93B8.86B7.95B
Deferred revenue
0.0062.00M0.000.000.000.000.000.000.000.000.00
Short-term debt
3.46B5.81B5.74B2.97B1.78B4.21B5.44B3.78B1.99B4.82B1.92B
Other current liabilities
17.76B23.42B1.18B2.47B2.82B5.60B5.83B4.82B4.88B23.00M0.00
Total current liabilities
93.10B88.69B84.61B79.19B69.42B67.81B62.02B53.30B44.01B30.65B26.25B
Long-term debt
57.22B72.88B60.53B58.64B50.48B51.97B59.21B64.70B71.44B22.18B25.62B
Other non-current liabilities
10.50B-2.16B13.64B14.92B15.79B13.39B14.24B14.06B14.78B1.61B1.55B
Lease obligations, current
1.92B0.001.75B1.74B1.68B1.65B1.64B1.60B0.000.000.00
Lease obligations, long-term
12.70B14.91B14.90B16.03B16.80B18.18B18.76B18.93B0.000.000.00
Total liabilities
177.39B185.68B177.49B173.09B156.51B157.62B161.01B158.28B137.91B57.44B57.63B
Common stock and paid-in capital
18.00M18.00M18.00M48.99B48.19B47.38B46.51B45.97B45.44B32.10B17.00M
Retained earnings
66.71B61.20B62.84B61.60B56.40B54.91B49.64B45.11B40.91B43.56B38.98B
Accumulated other comprehensive income
-595.00M406.00M-120.00M-297.00M-1.26B965.00M1.41B1.02B102.00M-165.00M-305.00M
Shareholders' equity
80.50B75.21B75.56B76.46B71.47B75.08B69.39B63.86B58.23B37.69B36.83B
Minority interest
192.00M168.00M170.00M175.00M300.00M306.00M312.00M306.00M318.00M4.00M4.00M
75.30B93.59B82.92B79.39B70.73B76.00B85.04B89.00B73.43B27.00B27.53B
Net cash
-60.41B-82.94B-71.93B-67.93B-55.01B-63.47B-74.19B-80.95B-66.85B-25.20B-24.07B
Working capital
-13.71B-13.98B-15.96B-11.33B-3.79B-7.80B-5.65B-3.00B1.23B581.00M4.79B
Book value per share
62.3559.1859.8759.2754.0256.4952.8148.9455.7736.8134.13
Tangible book value
-29.21B-35.77B-43.04B-44.05B-31.48B-33.07B-41.31B-49.01B-56.98B-14.39B-14.93B
Tangible book value per share
-22.62-28.14-34.10-34.14-23.80-24.88-31.43-37.55-54.58-14.05-13.84
Current ratio
0.850.840.810.860.950.890.910.941.031.021.18
Debt to equity
0.941.241.101.040.991.011.231.391.260.720.75

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about CVS HEALTH's cash and debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.